Home » Stocks » MOTS

Motus GI Holdings, Inc. (MOTS)

Stock Price: $1.53 USD -0.08 (-4.97%)
Updated Jan 22, 2021 4:00 PM EST - Market closed
Market Cap 49.33M
Revenue (ttm) 161,000
Net Income (ttm) -20.80M
Shares Out 30.42M
EPS (ttm) -0.71
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 22
Last Price $1.53
Previous Close $1.61
Change ($) -0.08
Change (%) -4.97%
Day's Open 1.50
Day's Range 1.39 - 1.57
Day's Volume 3,374,180
52-Week Range 0.50 - 2.19

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
GlobeNewsWire - 1 week ago

Regulatory approval for enhanced system is a key milestone that supports evaluation of strategic partnership opportunities in the EU - - - U.S. commercial rollout of Pure-Vu® GEN2 System enhan...

GlobeNewsWire - 1 week ago

Receives additional EU Patent for the Pure-Vu® System that protects the design of its fecal waste evacuation channels Receives additional EU Patent for the Pure-Vu® System that protects the de...

GlobeNewsWire - 1 month ago

FORT LAUDERDALE, Fla., Nov. 25, 2020 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that ...

Seeking Alpha - 2 months ago

Motus GI Holdings, Inc.'s (MOTS) CEO Tim Moran on Q3 2020 Results - Earnings Call Transcript

GlobeNewsWire - 2 months ago

FORT LAUDERDALE, Fla., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that ...

GlobeNewsWire - 2 months ago

FORT LAUDERDALE, Fla., Nov. 03, 2020 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc. , (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions to h...

GlobeNewsWire - 2 months ago

FORT LAUDERDALE, Fla., Oct. 29, 2020 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that ...

GlobeNewsWire - 3 months ago

FORT LAUDERDALE, Fla., Oct. 13, 2020 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that ...

GlobeNewsWire - 4 months ago

FORT LAUDERDALE, Fla., Sept. 14, 2020 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions th...

GlobeNewsWire - 4 months ago

FORT LAUDERDALE, Fla., Sept. 10, 2020 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc. , (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions ...

GlobeNewsWire - 4 months ago

FORT LAUDERDALE, Fla., Aug. 28, 2020 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions tha...

Seeking Alpha - 5 months ago

Motus GI Holdings, Inc.'s (MOTS) CEO Tim Moran on Q2 2020 Results - Earnings Call Transcript

Zacks Investment Research - 5 months ago

Motus GI Holdings, Inc. (MOTS) delivered earnings and revenue surprises of 28.57% and -95.00%, respectively, for the quarter ended June 2020.

Benzinga - 5 months ago

Shares of Motus GI Hldgs (NASDAQ: MOTS) were flat after the company reported Q2 results.

GlobeNewsWire - 6 months ago

FORT LAUDERDALE, Fla., July 21, 2020 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc. , (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions t...

GlobeNewsWire - 7 months ago

FORT LAUDERDALE, Fla., June 15, 2020 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions tha...

GlobeNewsWire - 7 months ago

Live moderated video webcast discussion with CEO, Tim Moran on Monday, June 15, at 2:00 PM ET, immediately followed by an interactive Q&A session Live moderated video webcast discussion with C...

Seeking Alpha - 8 months ago

Motus GI Holdings, Inc. (MOTS) CEO Tim Moran on Q1 2020 Results - Earnings Call Transcript

Zacks Investment Research - 8 months ago

Motus GI Holdings, Inc. (MOTS) delivered earnings and revenue surprises of -4.55% and -81.33%, respectively, for the quarter ended March 2020.

GlobeNewsWire - 8 months ago

FORT LAUDERDALE, Fla., May 14, 2020 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc. , (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions th...

GlobeNewsWire - 8 months ago

FORT LAUDERDALE, Fla., May 05, 2020 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that...

Seeking Alpha - 9 months ago

Motus GI Holdings, Inc. (MOTS) CEO Tim Moran on Q4 2019 Results - Earnings Call Transcript

GlobeNewsWire - 9 months ago

FORT LAUDERDALE, Fla., March 30, 2020 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc. , (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions ...

Zacks Investment Research - 1 year ago

As of late, it has definitely been a great time to be an investor in Motus GI Holdings.

Seeking Alpha - 1 year ago

Motus GI Holdings, Inc. (MOTS) CEO Tim Moran on Q3 2019 Results - Earnings Call Transcript

Zacks Investment Research - 1 year ago

Motus GI Holdings, Inc. (MOTS) delivered earnings and revenue surprises of 28.00% and -97.00%, respectively, for the quarter ended September 2019.

GuruFocus - 1 year ago

The GuruFocus All-in-One Screener can be used to find insider trades from the past week.

Other stocks mentioned: CHRS, DDMXU, FND, HDS, KRTX, OCX

About MOTS

Motus GI Holdings, a medical technology company, provides endoscopy solutions that enhance clinical outcomes and the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions in the United States and Israel. Its flagship product is the Pure-Vu system, a medical device to facilitate the cleaning of a poorly prepared colon during the colonoscopy procedure. The company is based in Fort Lauderdale, Florida.

Industry
Diagnostics & Research
IPO Date
Feb 14, 2018
CEO
Timothy Moran
Employees
49
Stock Exchange
NASDAQ
Ticker Symbol
MOTS
Full Company Profile

Financial Performance

In 2019, MOTS's revenue was $107,000, an increase of 197.22% compared to the previous year's $36,000. Losses were -$23.09 million, 3.72% more than in 2018.

Financial Statements

Analyst Forecasts

According to 6 analysts, the average rating for MOTS stock is "Buy." The 12-month stock price forecast is 2.50, which is an increase of 63.40% from the latest price.

Price Target
$2.50
(63.40% upside)
Analyst Consensus: Buy